USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DERMAXON, LLC
Address:
6610 JUSTIN CT
MISSOULA, MT 59803-2969
Phone:
(832) 677-3756
URL:
N/A
EIN:
146223521
DUNS:
078771732
Number of Employees:
2
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $225,000.00 1

Award List:

Inhibition of retinoic acid metabolism for reversal of cognitive deficits in AD

Award Year / Program / Phase:
2013 / STTR / Phase I
Award Amount:
$225,000.00
Agency:
HHS
Principal Investigator:
Fanny Astruc-diaz – 406-243-4354
Research Institution:
UNIVERSITY OF WASHINGTON
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a progressive and ultimately fatal neurodegenerative disease that affects more than five million people in the USA. Currently there is no cure for AD. Available medicines are aimed only at temporarily reducing symptoms and slowing… More